Which of the listed medications (pantoprazole delayed‑release, sennosides, docusate sodium, ipratropium bromide inhaler [Atrovent HFA], lorazepam [Ativan], sitagliptin/metformin [Janumet], empagliflozin [Jardiance], lisinopril/hydrochlorothiazide, and atorvastatin) are known to cause dry mouth and/or a metallic taste?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications Causing Dry Mouth and Metallic Taste

Among your medications, ipratropium bromide (Atrovent HFA), metformin (in Janumet), and lorazepam (Ativan) are the primary culprits for dry mouth, while metformin is specifically known for causing metallic taste.

Primary Offenders

Ipratropium Bromide (Atrovent HFA)

  • Dry mouth occurs in 2-4% of patients taking ipratropium bromide, with 1.6% of patients reporting drug-related dry mouth in controlled trials 1
  • Taste perversion (bitter taste) affects 0.9% of patients 1
  • As an anticholinergic medication, dry mouth is an expected class effect due to inhibition of salivary gland secretions 1, 2
  • Additional oral symptoms include throat irritation and stomatitis 1

Metformin (Component of Janumet 50-1000 mg)

  • Metallic taste is a well-recognized adverse effect of metformin, though the exact incidence varies
  • This side effect typically occurs early in treatment and may diminish over time
  • The extended-release formulation in Janumet may have a lower incidence compared to immediate-release metformin

Lorazepam (Ativan)

  • Benzodiazepines including lorazepam commonly cause dry mouth as a side effect
  • The mechanism involves central nervous system depression affecting autonomic regulation of salivary secretion
  • Dry mouth was specifically noted in clinical trials of benzodiazepines, though not quantified in the provided evidence 3

Secondary Contributors

Lisinopril/Hydrochlorothiazide

  • Hydrochlorothiazide (the diuretic component) can cause dry mouth through volume depletion and reduced salivary flow
  • ACE inhibitors like lisinopril may also contribute to altered taste perception in some patients
  • The combination effect may be additive

Pantoprazole

  • Proton pump inhibitors are not typically associated with dry mouth or metallic taste as primary side effects
  • The evidence provided does not list these as common adverse reactions 4

Medications Unlikely to Cause These Symptoms

  • Atorvastatin: Not associated with dry mouth or metallic taste 5
  • Empagliflozin (Jardiance): Not reported to cause these symptoms 6, 7
  • Sennosides/Docusate sodium: Gastrointestinal effects predominate; oral symptoms not characteristic

Clinical Management Considerations

The intranasal use of Atrovent HFA as prescribed is off-label (it is FDA-approved for inhalation only), which may alter the side effect profile 1. When used intranasally, local anticholinergic effects on nasal and oral mucosa may be more pronounced.

Multiple medication synergy: You are taking at least three medications (ipratropium, metformin, and lorazepam) that can cause dry mouth, creating an additive effect that may be more bothersome than any single agent alone.

Practical mitigation strategies include:

  • Frequent sips of water throughout the day
  • Sugar-free gum or lozenges to stimulate saliva production
  • Saliva substitutes if symptoms are severe
  • For metallic taste from metformin: taking with food, using mints, or discussing extended-release formulations with your provider

Related Questions

Which of the following is NOT an indication for ipratropium bromide: allergic rhinitis, angioedema, acute asthma, or chronic obstructive pulmonary disease?
What are alternative medications to pantoprazole for acid suppression?
What alternative treatments can be used for acute bronchospasm in a patient who cannot receive ipratropium bromide due to hypersensitivity, narrow‑angle glaucoma, severe urinary retention/obstructive benign prostatic hyperplasia, gastrointestinal or urinary tract obstruction, or who is an infant younger than 2 years?
What is the appropriate treatment for a patient in their 40s, a former heavy smoker with chronic obstructive pulmonary disease (COPD) symptoms, presenting with a 1-month history of worsening cough, wheezing, and shortness of breath?
What is the optimal management for a 60‑year‑old woman with type 2 diabetes (A1c 8.3%) taking metformin 500 mg twice daily, empagliflozin (Jardiance) 10 mg daily, sitagliptin (Januvia) 100 mg daily, glipizide 5 mg twice daily, severe hypertriglyceridemia (506 mg/dL), borderline total cholesterol (198 mg/dL) with low HDL (34 mg/dL), estimated glomerular filtration rate 77 mL/min/1.73 m², and episodes of dizziness?
What is the normal reticulocyte count range for a newborn (0–28 days of age)?
What is the recommended approach to managing ventricular tachycardia, including assessment of hemodynamic stability, immediate synchronized cardioversion, antiarrhythmic drug selection (e.g., amiodarone, procainamide, lidocaine), electrolyte correction, beta‑blocker use, and indications for implantable cardioverter‑defibrillator placement?
What is the appropriate management for hemorrhagic gastritis?
Can pregnant women safely take Lexapro (escitalopram)?
How should a single episode of hematuria be evaluated and managed in an incontinent elderly patient?
What is the recommended treatment for peripheral arterial disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.